GB968980A - Measles virus vaccine - Google Patents
Measles virus vaccineInfo
- Publication number
- GB968980A GB968980A GB12640/64A GB1264064A GB968980A GB 968980 A GB968980 A GB 968980A GB 12640/64 A GB12640/64 A GB 12640/64A GB 1264064 A GB1264064 A GB 1264064A GB 968980 A GB968980 A GB 968980A
- Authority
- GB
- United Kingdom
- Prior art keywords
- measles virus
- vaccine
- culture
- cultures
- wet
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
- A61K39/165—Mumps or measles virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18434—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Virology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Pulmonology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Measles vaccine containing living attenuated measles virus which has been grown in chick embryo tissue culture is produced by infecting chick embryo tissue culture with attenuated measles virus, incubating the infected culture at 32 DEG C. and harvesting a wet vaccine by collecting the liquid from the culture. In the example, cultures of 7-11 day old chick embryos incubated at 37 DEG C. until a confluent cell sheet was formed were infected with measles virus after washing with balanced salt solution both before and after inoculation. The cultures were fed with medium SM199 and incubated at 32 DEG C. for 7-14 days. Cell debris was removed by centrifugation, the wet vaccine harvested and freeze dried after the addition of sorbitol.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12640/64A GB968980A (en) | 1961-09-08 | 1961-09-08 | Measles virus vaccine |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB12640/64A GB968980A (en) | 1961-09-08 | 1961-09-08 | Measles virus vaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB968980A true GB968980A (en) | 1964-09-09 |
Family
ID=10008426
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB12640/64A Expired GB968980A (en) | 1961-09-08 | 1961-09-08 | Measles virus vaccine |
Country Status (1)
| Country | Link |
|---|---|
| GB (1) | GB968980A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211843A (en) * | 1977-11-30 | 1980-07-08 | L'institut Armand-Frappier | Strain of measles virus and process of producing the same |
-
1961
- 1961-09-08 GB GB12640/64A patent/GB968980A/en not_active Expired
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4211843A (en) * | 1977-11-30 | 1980-07-08 | L'institut Armand-Frappier | Strain of measles virus and process of producing the same |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Vogel et al. | Adsorption-hemagglutination test for influenza virus in monkey kidney tissue culture | |
| US3214340A (en) | Stabilized viable attenuated measles virus vaccines and their production | |
| GB697351A (en) | Improved process for the manufacture of nerve sedatives | |
| Cormack et al. | Snow mold infection of alfalfa, grasses, and winter wheat by several fungi under artificial conditions | |
| GB968980A (en) | Measles virus vaccine | |
| GB1071922A (en) | Improvements in or relating to vaccines | |
| GB1000907A (en) | Attenuated live measles virus vaccine and method of production | |
| Daily et al. | Preservation of some algal cultures by lyophilization | |
| Parker et al. | Propagation of rabies virus in tissue culture. | |
| ES496780A0 (en) | A PROCEDURE FOR IN VITRO CELL CULTIVATION OF THE HEPATITIS B VIRUS. | |
| GB1133958A (en) | Process for the manufacture of a distemper vaccine | |
| GB1492930A (en) | Virus growth | |
| SU457229A3 (en) | Method for producing rubella vaccine | |
| GB1001689A (en) | Process for the production of a rabies vaccine | |
| GB839876A (en) | A process for the preparation of a vaccine containing live attenuated infectious canine hepatitis virus | |
| GB953603A (en) | Improvements in or relating to process for the preparation of the antiviral substance interferon | |
| FR2088089A1 (en) | Myxomatosis vaccine - by serial passage in chick embryo then in rabbit kidney cells | |
| GB767414A (en) | Improvements relating to the production of rabis vaccine | |
| GB1058340A (en) | Transmissible gastroenteritis vaccines and method of producing the same | |
| GB811411A (en) | Process for the production of a tissue culture fluid containing infectious hepatitisvirus and a killed vaccine therefrom | |
| SU143200A1 (en) | A method of making a dry virus vaccine against pseudo-poultry birds | |
| Gauger | Comparison of the rapid whole-blood K-antigen and the tube agglutination test for the detection of pullorum disease in turkeys | |
| Bishop | Further Observations upon a “Trichomonas” from Pond Water | |
| GB806950A (en) | Production of pharmaceutical preparations | |
| GB1065875A (en) | Measles vaccine attenuated through avian choric-allantoic membrane |